Trial Profile

A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sipuleucel-T (Primary)
Indications Prostate cancer
Focus Pharmacodynamics
Acronyms ProACT
Sponsors Dendreon Corporation

Most Recent Events

23 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
20 May 2014 According to a Dendreon Corporation media release, the results of this and two other trials (700007675 and 700195649) will be presented at the 2014 American Urological Association Annual Meeting.
06 May 2013 Results presented at the 108th Annual Meeting of the American Urological Association.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com